Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Ruiz-Fernández

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Case Reports in Neurology|July 30, 2021
Initial Cerebellar Ataxia in Hereditary Adult-Onset Primary Lateral SclerosisJosé Gazulla, Silvia Izquierdo-Alvarez, Emilio Ruiz-Fernández, et al.
Case Reports in Neurology|July 12, 2021
Episodic Vestibulocerebellar Ataxia Associated with a <i>CACNA1G</i> Missense VariantJosé Gazulla, Silvia Izquierdo-Alvarez, Emilio Ruiz-Fernández, et al.
Molecular Neurobiology|June 17, 2026
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple SclerosisPascual Torres, Anna Gil Sánchez, Agustín Sancho-Saldaña, et al.
Journal of Neurology|March 18, 2023
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapiesPascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Case Reports in Neurology|July 30, 2021
Initial Cerebellar Ataxia in Hereditary Adult-Onset Primary Lateral SclerosisJosé Gazulla, Silvia Izquierdo-Alvarez, Emilio Ruiz-Fernández, et al.
Case Reports in Neurology|July 12, 2021
Episodic Vestibulocerebellar Ataxia Associated with a <i>CACNA1G</i> Missense VariantJosé Gazulla, Silvia Izquierdo-Alvarez, Emilio Ruiz-Fernández, et al.
Molecular Neurobiology|June 17, 2026
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple SclerosisPascual Torres, Anna Gil Sánchez, Agustín Sancho-Saldaña, et al.
Journal of Neurology|March 18, 2023
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapiesPascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, et al.
Pageof 1